Stephen Crystal
Overview
Explore the profile of Stephen Crystal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
253
Citations
5137
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Mannes Z, Wheeler-Martin K, Terlizzi K, Hasin D, Perry A, Pamplin 2nd J, et al.
Prev Med
. 2023 Nov;
177:107789.
PMID: 38016582
Objective: The COVID-19 pandemic contributed to healthcare disruptions for patients with chronic pain. Following initial disruptions, national policies were enacted to expand access to long-term opioid therapy (LTOT) for chronic...
22.
Tipping A, Nowels M, Moore C, Samples H, Crystal S, Olfson M, et al.
J Subst Use Addict Treat
. 2023 Nov;
157:209218.
PMID: 37984564
Introduction: Following a nonfatal opioid overdose, patients are at high risk for repeat overdose. The objective of this study was to examine the association of MOUD after nonfatal opioid overdose...
23.
Perry A, Wheeler-Martin K, Hasin D, Terlizzi K, Mannes Z, Jent V, et al.
Drug Alcohol Depend
. 2023 Nov;
253:111023.
PMID: 37984034
Background: The COVID-19 pandemic's impact on utilization of medications for opioid use disorder (MOUD) among patients with opioid use disorder (OUD) and chronic pain is unclear. Methods: We analyzed New...
24.
Hoffman K, Milazzo F, Williams N, Samples H, Olfson M, Diaz I, et al.
Psychol Med
. 2023 Nov;
54(7):1419-1430.
PMID: 37974483
Background: Chronic pain has been extensively explored as a risk factor for opioid misuse, resulting in increased focus on opioid prescribing practices for individuals with such conditions. Physical disability sometimes...
25.
Treitler P, Enich M, Bowden C, Mahone A, Lloyd J, Crystal S
J Subst Use Addict Treat
. 2023 Nov;
156:209212.
PMID: 37935350
Introduction: Medications for opioid use disorder (MOUD) are the most effective treatment for opioid use disorder (OUD) but remain underutilized. To reduce barriers to MOUD prescribing and increase treatment access,...
26.
Horton D, Yang Y, Neikirk A, Huang C, Crystal S, Davidow A, et al.
J Clin Rheumatol
. 2023 Oct;
29(8):388-395.
PMID: 37798830
Background/objective: Given limited information on health care and treatment utilization for juvenile idiopathic arthritis (JIA) during the pandemic, we studied JIA-related health care and treatment utilization in a commercially insured...
27.
Miles J, Treitler P, Lloyd J, Samples H, Mahone A, Hermida R, et al.
Health Aff (Millwood)
. 2023 Oct;
42(10):1431-1438.
PMID: 37782874
We examined Medicare Part D claims from the period 2015-19 to identify state and national racial and ethnic disparities in buprenorphine receipt among Medicare disability beneficiaries with diagnosed opioid use...
28.
Racial/ethnic disparities in timely receipt of buprenorphine among Medicare disability beneficiaries
Miles J, Treitler P, Hermida R, Nyaku A, Simon K, Gupta S, et al.
Drug Alcohol Depend
. 2023 Sep;
252:110963.
PMID: 37748421
Background: Medicare disability beneficiaries (MDBs) have disproportionately high risk of opioid use disorder (OUD) and related harms given high rates of comorbidities and high-dose opioid prescribing. Despite this increased risk,...
29.
Perry A, Wheeler-Martin K, Terlizzi K, Krawczyk N, Jent V, Hasin D, et al.
Pain Med
. 2023 Aug;
24(12):1296-1305.
PMID: 37651585
Objective: To assess whether chronic pain increases the risk of COVID-19 complications and whether opioid use disorder (OUD) differentiates this risk among New York State Medicaid beneficiaries. Design, Setting, And...
30.
Mahone A, Enich M, Treitler P, Lloyd J, Crystal S
Am J Drug Alcohol Abuse
. 2023 Jul;
49(5):606-617.
PMID: 37506336
In the US, seventy percent of drug-related deaths are attributed to opioids. In response to the ongoing opioid crisis, New Jersey's (NJ) Medicaid program implemented the MATrx model to increase...